V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260019055 | 260009393 | 1.56 | 118.9 | Curative (C) | 2017-09-14 | 2017-09-19 | CVP | N | N | 260028305 | BLEOMYCIN + VINCRISTINE |
| 260019056 | 260009411 | null | null | Palliative (P) | 2018-03-17 | 2018-06-30 | ICE + GCSF | N | null | 260028377 | CARBO + THIOTEPA + TOPOTECAN |
| 260019057 | 260014497 | 1.78 | 67.4 | Curative (C) | 2016-07-31 | 2016-08-05 | VIP | 2 | N | 260028405 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260019058 | 260009434 | 1.88 | 95.2 | Palliative (P) | 2017-07-08 | 2017-07-15 | CARBOPLATIN + ETOPOSIDE | N | N | 260028436 | BLEOMYCIN |
| 260019059 | 260009443 | null | null | Curative (C) | 2016-04-20 | 2016-10-01 | Cisplatin + Radiotherapy | 99 | null | 260028451 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260019060 | 260009454 | 1.65 | 48.9 | Palliative (P) | 2017-06-16 | 2017-06-23 | DOCETAXEL + TRASTUZUMAB | N | N | 260028487 | DOCETAXEL + TRASTUZUMAB |
| 260019061 | 260014515 | 1.67 | 60 | Curative (C) | null | 2013-10-05 | BLEOMYCIN + VINCRISTINE | N | N | 260028569 | METHOTREXATE |
| 260019062 | 260009497 | 1.63 | 74.5 | Palliative (P) | 2017-05-26 | 2017-12-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260028618 | TRASTUZUMAB |
| 260019063 | 260009501 | null | 59.15 | Curative (C) | 2017-10-26 | 2018-06-30 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260028633 | CHOP |
| 260019064 | 260009502 | 1.8 | 102 | Palliative (P) | 2018-03-08 | 2018-03-09 | R Chlorambucil | 02 | N | 260028634 | BLEOMYCIN |
| 260019065 | 260009507 | null | 98.8 | Disease modification (D) | null | 2016-05-29 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260028641 | METHOTREXATE |
| 260019066 | 260009522 | 1.84 | 96 | Curative (C) | 2016-03-27 | 2016-04-19 | Paclitaxel Priming | N | N | 260028731 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260019067 | 260018176 | 1.67 | 81 | Palliative (P) | 2019-06-10 | 2019-06-10 | BLEOMYCIN + VINCRISTINE | 2 | N | 260028757 | TRASTUZUMAB |
| 260019068 | 260014541 | 1.76 | 102.4 | Adjuvant (A) | 2014-06-02 | 2014-06-03 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260028790 | ICE |
| 260019069 | 260009547 | null | 80.2 | Disease modification (D) | 2015-09-02 | 2015-09-17 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260028814 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260019070 | 260009556 | 0 | null | Palliative (P) | 2015-09-06 | 2015-09-06 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028854 | OBINUTUZUMAB |
| 260019071 | 260009563 | 1.8 | 87.8 | Curative (C) | 2018-01-31 | 2018-03-28 | BLEOMYCIN | N | N | 260028878 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260019072 | 260009581 | 1.6 | 111.8 | Neo-adjuvant (N) | 2019-04-26 | 2019-05-02 | Docetaxel + Trastuzumab (Maint) | N | N | 260028943 | CHOP |
| 260019073 | 260009596 | 1.69 | null | Curative (C) | 2018-08-12 | 2019-04-25 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | null | 260028993 | METHOTREXATE HIGH DOSE |
| 260019074 | 260009606 | 1.72 | 78.9 | Disease modification (D) | 2019-02-17 | 2019-02-27 | Gemcitabine + Oxaliplatin | 2 | N | 260029017 | IFOSFAMIDE + PACLITAXEL |
| 260019075 | 260009609 | null | null | Disease modification (D) | 2018-09-19 | 2018-09-26 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 260029021 | CARBOPLATIN + ETOPOSIDE |
| 260019076 | 260016982 | 1.58 | 107.9 | Palliative (P) | 2018-08-18 | 2019-02-24 | NIVOLUMAB | 02 | Y | 260029065 | CYTARABINE HD + METHOTREXATE HD |
| 260019077 | 260009625 | 0 | null | Palliative (P) | 2018-05-23 | 2018-06-07 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | null | Y | 260029067 | PACLITAXEL |
| 260019078 | 260014594 | null | null | Palliative (P) | 2015-09-29 | 2015-10-20 | CVP | N | N | 260029198 | ICE |
| 260019079 | 260009666 | 1.56 | 65 | Curative (C) | 2018-12-23 | 2018-12-31 | Cisplatin + Radiotherapy | N | N | 260029207 | DOCETAXEL + TRASTUZUMAB |
| 260019080 | 260014608 | 1.78 | 85.7 | null | null | 2017-12-27 | Gemcitabine + Oxaliplatin | N | null | 260029313 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260019081 | 260009706 | null | null | Curative (C) | 2015-09-30 | 2015-10-04 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | null | null | 260029348 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260019082 | 260009726 | 1.7 | 85.8 | Palliative (P) | 2015-09-23 | 2015-10-01 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260029421 | CISPLATIN + RT |
| 260019083 | 260009729 | 1.57 | 94.2 | Palliative (P) | 2018-11-18 | 2018-11-19 | ICE | 2 | N | 260029426 | TRASTUZUMAB |
| 260019084 | 260009731 | 1.67 | null | Curative (C) | 2015-10-08 | 2015-10-08 | IPO | 2 | N | 260029427 | POMB/ACE |
| 260019085 | 260009738 | 1.67 | 46.2 | Curative (C) | null | 2015-11-16 | Methotrexate High Dose (3g/m2) | N | null | 260029461 | NIVOLUMAB |
| 260019086 | 260009741 | 1.72 | 46 | Disease modification (D) | 2018-02-28 | 2018-02-28 | BLEOMYCIN | N | N | 260029465 | RMS 2005 TRIAL |
| 260019087 | 260009744 | 1.59 | 85 | Curative (C) | 2016-12-26 | 2016-12-26 | CARBOPLATIN + ETOPOSIDE | N | N | 260029472 | CARBOPLATIN + ETOPOSIDE |
| 260019088 | 260009753 | 1.76 | 82.4 | Palliative (P) | 2019-03-11 | 2019-03-16 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 260029508 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260019089 | 260014638 | null | null | Curative (C) | 2016-05-10 | 2016-06-03 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 260029509 | PACLITAXEL |
| 260019090 | 260009770 | 1.91 | 87.5 | Palliative (P) | 2020-01-15 | 2020-02-06 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029532 | CYTARABINE + METHOTREXATE HD |
| 260019091 | 260018803 | null | 56.3 | Curative (C) | 2018-06-01 | 2018-09-26 | POMB/ACE | 02 | N | 260029590 | PEMBROLIZUMAB |
| 260019092 | 260009808 | null | 54.55 | Curative (C) | null | 2016-07-15 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260029660 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260019093 | 260009813 | 1.62 | null | Disease modification (D) | 2018-11-02 | 2018-11-02 | CHOP - 21 days | null | null | 260029667 | CISPLATIN |
| 260019094 | 260009817 | null | 69 | Palliative (P) | 2018-04-22 | 2018-05-01 | Pazopanib | N | N | 260029691 | GEMCITABINE + OXALIPLATIN |
| 260019095 | 260009834 | 1.7 | 61.8 | Palliative (P) | 2014-06-29 | 2014-07-15 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029746 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260019096 | 260009868 | null | 47.6 | Curative (C) | 2018-03-01 | 2018-05-03 | Cisplatin 7 day | 2 | N | 260029960 | CHOP |
| 260019097 | 260009872 | 1.74 | 81.5 | Adjuvant (A) | 2016-08-28 | 2016-08-29 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 260029988 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260019098 | 260009875 | 1.65 | 53.8 | Curative (C) | 2018-10-08 | 2018-10-14 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260030004 | BOP |
| 260019099 | 260009904 | 0 | 63 | Disease modification (D) | null | 2015-07-04 | POMB/ACE | N | N | 260030095 | POMB/ACE |
| 260019100 | 260009908 | 1.9 | null | Adjuvant (A) | 2019-03-08 | 2019-03-11 | PCV | N | N | 260030119 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260019101 | 260009926 | 1.72 | 58.4 | Palliative (P) | 2018-11-21 | 2019-01-16 | Pazopanib | null | null | 260006047 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 260019102 | 260009938 | 1.88 | 66.8 | Palliative (P) | 2016-05-25 | 2016-06-06 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | 2 | N | 260007261 | IPO |
| 260019103 | 260009961 | 1.5 | 66 | Curative (C) | 2016-02-19 | 2016-03-21 | IVE-R | N | N | 260007890 | DHAP |
| 260019104 | 260009978 | 1.67 | 73.5 | Adjuvant (A) | 2018-07-18 | 2018-08-01 | BLEOMYCIN + VINCRISTINE | N | N | 260008307 | CISPLATIN |